STOCK TITAN

Healthy Extracts Launches New Clinical Study Investigating UBN ACTIVATE™ Effect on Golfers’ Energy, Focus and Scores

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Very Positive)
Rhea-AI Summary

Healthy Extracts Inc. (OTCQB: HYEX) has initiated a prospective trial to evaluate the impact of its UBN ACTIVATE™ supplement on golf performance. The study will assess energy conservation, mental focus, and overall scores among 10 golfers playing nine holes, both with and without the supplement. Conducted by the Colorado Center for Health and Sports Science, the trial aims to connect mental focus to scoring outcomes. Results are expected in October, with indications of positive preliminary feedback from users.

Positive
  • Initiation of a prospective trial to study the effects of UBN ACTIVATE on golf performance.
  • Study aims to correlate mental focus with golf scores, a first of its kind.
  • Positive preliminary feedback from users suggesting improved performance.
  • Plans for future trials examining the supplement's effect on athletes in other sports.
Negative
  • None.

LAS VEGAS, July 26, 2022 (GLOBE NEWSWIRE) -- Healthy Extracts Inc. (OTCQB: HYEX), a leading innovator of clinically proven plant-based products for heart and brain health, has launched a prospective, investigational trial to study the effect of its UBN ACTIVATE™ on golf performance.

The study will investigate if the natural brain activation supplement can improve golfers’ energy conservation, mental focus and score during each round.

During play, 10 subjects will wear metabolic measurement equipment to evaluate on-course energy expenditure. They will then play nine holes of golf with and without taking ACTIVATE, and rate their overall focus, tee shots, second shots and short game accordingly. Each subject will also be evaluated with their preferred mode of golf transport: pushcart, electric trolley or motor cart.

Neil Wolkodoff, PhD, medical program director of the Colorado Center for Health and Sports Science, will be the lead investigator for the study. An avid golfer, he has authored several books about the physiology of the sport, including Physical Golf and Core Powered Golf.

According to Dr. Wolkodoff, this is the first energy expenditure study of golf that will correlate mental focus to scores.

The study is sponsored by the Colorado Center for Health & Sports Science and the Colorado Golf Association, with the testing conducted at the Common Ground Golf Course in Aurora, Colorado. The study is expected to conclude in October, with the result to be published in a peer-reviewed, scientific journal.

The study is expected to build upon the success of a randomized, placebo-controlled clinical trial published in Annals of Reviews and Research that highlighted the ability of ACTIVATE to naturally increase key brain activity by as much as 46%.

Clinical studies have shown ACTIVATE dramatically improves human cognitive behavior and mental focus by activating areas of the brain primarily responsible for attention, memory, mood, and reaction times. These benefits are a result of the company’s KETONOMICS® proprietary formulations clinically shown to quickly generate strong and sustained ketone levels in the brain.

Duke Pitts, president of Healthy Extracts, stated: “We anticipate significant results from this observational trial of the effect of ACTIVATE on golf performance. We’ve received preliminary positive indications, including anecdotal reports from users stating that their golf game improved substantially. We’re now looking forward to this study to provide actual results that will confirm these observations.”

According to Rich “The G-man” Goins, noted radio sportscaster and ACTIVATE user: “I attribute some of my best golf rounds in the last six months to taking UBN ACTIVATE. I’m definitely more focused and calm while putting, and have the mental edge in making shots that help me score and win tournaments.”

Added Pitts: “Looking at our sales channels, we see many B2B opportunities with major golf companies that would be interested in an all-natural supplement that could provide golfers an edge in their game. We also anticipate attracting golfers under our brand influencer program, where we can secure key product endorsements.”

The company plans to launch additional clinical trials studying ACTIVATE’s effect on athletes in other sports, such as martial arts.

About UBN ACTIVATE
UBN ACTIVATE is a specialized version of Healthy Extracts’ proprietary, patent-protected formulations. The company’s unique products are the result of more than 20 years of scientific research, including multiple clinical studies on the key ingredients.

The ingredients are naturally derived and contain no caffeine or added sugar, and its powerful brain activation benefits have been shown to last eight hours or more.

The formulation also contains a proprietary blend of other effective ingredients, including a naturally sourced spearmint extract that has been clinically shown to support mental focus during the day without disrupting sleep at night and a protective free radical scavenger found naturally in the body that helps the brain function optimally, while promoting a healthy mood and supporting healthy sleep habits.

It also includes a unique natural marigold extract that is scientifically shown to block blue light, enhance brain carotenoid antioxidant levels and replenish lutein, which is critical for optimum eye health.

Healthy Extracts’ product research and development is focused on the brain health supplement market that is expected to grow at an 8% compounded annual growth rate (CAGR) to reach $15.7 billion by 2030.

To learn more about ACTIVATE and Healthy Extracts’ other products, go to tryubn.com and bergametna.com.

About Healthy Extracts “Live Life Young Again”
Healthy Extracts Inc. is a platform for developing or acquiring science-forward, clinically proven, plant-based proprietary products in select high-growth categories within the multibillion-dollar nutraceuticals market.

The company’s subsidiaries, BergametNA™ and Ultimate Brain Nutrients™ (UBN), offer nutraceutical natural heart and brain health supplements. This includes the only heart health supplement containing Citrus Bergamot SuperFruit™. This superfruit is known to have the highest quality and concentration of polyphenols and flavonoids, and with healthy heart benefits backed by more than 17 clinical studies.

UBN KETONOMICS® proprietary formulations have been clinically shown to support brain health, including memory, cognition, focus and neuro-energy. UBN is pursuing intellectual property license opportunities for monetizing its IP portfolio of multiple issued and pending patents.

For more information visit: healthyextractsinc.com, bergametna.com or tryubn.com.

Forward-Looking Statements and Safe Harbor Notice

All statements other than statements of historical facts included in this press release are “forward-looking statements” (as defined in the Private Securities Litigation Reform Act of 1995). Such forward-looking statements include our expectations and those statements that use forward-looking words such as “projected,” “expect,” “possibility” and “anticipate.” The achievement or success of the matters covered by such forward-looking statements involve significant risks, uncertainties and assumptions. Actual results could differ materially from current projections or implied results. Investors should read the risk factors set forth in the Company’s Annual Report on Form 10-K filed with the SEC on April 1, 2022, and future periodic reports filed with the SEC. All of the Company’s forward-looking statements are expressly qualified by all such risk factors and other cautionary statements.

The Company cautions that statements and assumptions made in this news release constitute forward-looking statements and make no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. The information set forth herein speaks only as of the date hereof. The Company and its management undertake no obligation to revise these statements following the date of this news release.

Food and Drug Administration Disclosure

The product and formulation featured in this release is not for use by or sale to persons under the age of 12. This product should be used only as directed on the label. Consult with a physician before use if you have a serious medical condition or use prescription medications. A doctor’s advice should be sought before using this and any supplemental dietary product. These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease.

BergametNA™, Ultimate Brain Nutrients™, UBN™, Citrus Bergamot SuperFruit™ and F4T® are registered trademarks of Healthy Extracts Inc.™

Healthy Extracts Company Contact
Duke Pitts, President
Healthy Extracts Inc.
Tel (720) 463-1004
Email contact

Investor & Media Contact
Ronald Both or Justin Lumley
CMA Investor & Media Relations
Tel (949) 432-7566
Email contact

Media Contact:
Tim Randall
CMA
Tel (949) 432-7572
Email Contact

Photos accompanying this announcement are available at:

https://www.globenewswire.com/NewsRoom/AttachmentNg/805c9c95-2ea2-42b0-9d38-6024ad2ecbaa

https://www.globenewswire.com/NewsRoom/AttachmentNg/aa9f00d5-2b75-4891-b473-9eaa174d4a05


FAQ

What is the purpose of the trial involving UBN ACTIVATE for golfers?

The trial aims to investigate whether UBN ACTIVATE can enhance golfers' energy conservation, mental focus, and overall performance.

When is the UBN ACTIVATE trial expected to conclude?

The trial is expected to conclude in October 2022.

Who is conducting the trial for UBN ACTIVATE?

The trial is being conducted by the Colorado Center for Health and Sports Science, with Dr. Neil Wolkodoff as the lead investigator.

What feedback has Healthy Extracts received about UBN ACTIVATE?

Healthy Extracts has received preliminary positive feedback, including anecdotal reports from users claiming improved golf performance.

What are the future plans for Healthy Extracts regarding UBN ACTIVATE?

Healthy Extracts plans to conduct additional clinical trials to explore UBN ACTIVATE's effects on various athletes in other sports.

HEALTHY EXTRACTS INC

OTC:HYEX

HYEX Rankings

HYEX Latest News

HYEX Stock Data

3.62M
808.80k
72.94%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Henderson